Skip to main content

Table 1 Selected characteristics of women in the BREAST Stamp Project with benign breast disease, stratified by menopausal status

From: Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease

Characteristic

Premenopausal: n = 155

Postmenopausal: n = 73

 

age = 40–55 (median 47) years

age = 44–64 (median 57) years

 

Number

Percent

Number

Percent

P t

Age at biopsy (years)

 40–44

53

34.2

1*

1.4

<0.001

 45–49

64

41.3

2

2.7

 

 50–54

37

23.9

21

28.8

 

 55–59

1

0.6

24

32.9

 

 60–65

0

0

25

34.2

 

Race/Ethnicity

 White, non-Hispanic

147

94.8

67

91.8

0.37

 Other

8

5.2

6

8.2

 

Body mass index (kg/m2)

 <25

84

54.2

32

43.8

0.34

 25.0–29.9

35

22.6

21

28.8

 

 ≥30

36

23.2

20

27.4

 

Age at menarche (years)

 ≤12

56

36.1

30

41.1

0.36

 13

60

38.7

21

28.8

 

 ≥14

38

24.5

21

28.8

 

 Missing

1

0.6

1

1.4

 

Parity

 Nulliparous

41

26.4

17

23.3

0.12

 1

13

8.4

14

19.2

 

 2

65

41.9

29

39.7

 

 ≥3

36

23.2

13

17.8

 

Age at first birth (years)

 <25

37

23.9

33

45.2

0.01

 25–29

44

28.4

14

19.2

 

 ≥30

33

21.3

9

12.3

 

Oral contraceptive use

 Never

23

14.8

10

13.7

0.82

 Ever

132

85.2

63

86.3

 

Type of menopause

 Natural

~

~

53

72.6

~

 Surgical

~

~

3

4.1

 

 Type unknown

~

~

17

23.3

 

Age at menopause (years)

 ≤45

~

~

21

28.8

~

 46–49

~

~

13

17.8

 

 50–52

~

~

19

26

 

 ≥53

~

~

13

17.8

 

 Unknown

~

~

7

9.6

 

Any menopausal hormone therapy usea

 Never

135

87.1

49

67.1

<0.001

 Ever

19

12.3

24

32.9

 

 Missing

1

0.6

0

0

 

Cigarette smoking (100+ cigarettes/lifetime)

 Never

83

53.5

28

38.4

0.07

 Former

55

35.5

31

42.5

 

 Current

10

6.5

10

13.7

 

 Missing/Unknown

7

4.5

4

5.5

 

Family history of breast cancerb

 0

114

73.5

52

71.2

0.96

 ≥1

41

26.5

19

26

 

 Missing

0

0

2

2.7

 
  1. aData on any use of menopausal hormone therapy (MHT) missing for one premenopausal woman, and current MHT use missing for one postmenopausal woman who reported ever use. bWomen with at least one first degree relative with a diagnosis of breast cancer. P t is the value for testing for differences in distribution by menopausal status using the chi square (Χ 2) test or Fisher's exact test when the number for a category was <5. *This woman experienced natural menopause